{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:56:17Z","timestamp":1788386177904,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jpba.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T17:17:15Z","timestamp":1365268635000},"page":"138-145","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Reproducibility of the anti-Factor Xa and anti-Factor IIa assays applied to enoxaparin solution"],"prefix":"10.1016","volume":"81-82","author":[{"given":"C\u00e9line","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Savadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Agut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.03.021_bib0005","unstructured":"European Directorate for the Quality of Medicines and Health Care. European Pharmacopoeia Monograph PA\/PH\/Exp. 6\/T (09) 42 PUB. Available from: http:\/\/www.edqm.eu, (accessed February 2012)."},{"key":"10.1016\/j.jpba.2013.03.021_bib0010","unstructured":"US Pharmacopeia. Available from: http:\/\/www.usp.org, (accessed February 2012)."},{"key":"10.1016\/j.jpba.2013.03.021_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpba.2011.05.034","article-title":"Transfer of analytical procedures: a panel of strategies selected for risk management, with emphasis on an integrated equivalence-based comparative testing approach","volume":"56","author":"Agut","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.03.021_bib0020","series-title":"Confidence Intervals on Variance Components","author":"Burdick","year":"1992"},{"key":"10.1016\/j.jpba.2013.03.021_bib0025","unstructured":"Food and Drug Administration, USA. Guidance for Industry: Food Effect Bioavailability and Bioequivalence Studies. US Department of Health and Human Services, FDA (CDER), 2002."},{"key":"10.1016\/j.jpba.2013.03.021_bib0030","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/009286150103500424","article-title":"A unified approach for design and analysis of transfer studies for analytical methods","volume":"35","author":"Kringle","year":"2001","journal-title":"Drug Inf. J."},{"key":"10.1016\/j.jpba.2013.03.021_bib0035","series-title":"Accuracy (Trueness and Precision) of Measurement Methods and Results; Part 3 Intermediate Measures of the Precision of a Standard Measurement Method","author":"ISO 5725","year":"1994"},{"key":"10.1016\/j.jpba.2013.03.021_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1081\/BIP-200048826","article-title":"Two-sided tolerance intervals for balanced and unbalanced random effects models","volume":"15","author":"Hoffman","year":"2005","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.jpba.2013.03.021_bib0045","unstructured":"E. Gray, J. Hogwood, P. Rigsby, Collaborative study for value assignment of the 3rd international standard for low-molecular-weight heparin, report provided to the participant laboratories, May 2012."},{"key":"10.1016\/j.jpba.2013.03.021_bib0050","first-page":"59","article-title":"Collaborative study to establish the low-molecular-mass heparin for assay \u2013 European Pharmacopoeia Biological Reference Preparation","volume":"2004","author":"Gray","year":"2004","journal-title":"Pharmeuropa Biol."},{"key":"10.1016\/j.jpba.2013.03.021_bib0055","unstructured":"C. Martinez, C. Conocar, P. Anger, Study Assessing Analytical Attributes of Enoxaparin Generics Versus Compendial Monographs Sanofi-aventis, poster presented at the Parenteral Drug Association conference, Modern Biopharmaceutical manufacturing, Paris, 7\u20138 December 2010. Available online at: http:\/\/www.pda.org\/Presentation\/2010-PDA-Europe-Conference-on-Modern-Biopharmaceutical-Manufacturing.aspx."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:54:16Z","timestamp":1539748456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":11,"alternative-id":["S0731708513001398"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.03.021","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}